Tegileridine plus intercostal nerve block for pain after thoracoscopic lung removal
Official title: Study on the Analgesic Effect of Tegileridine Combined With Intercostal Nerve Block After Thoracoscopic Lung Resection
Run by Tongji Hospital · NCT07386626 · Data updated 2026-11-12
This trial will test whether giving a local intercostal nerve block together with patient-controlled tegileridine improves pain control for adults having thoracoscopic lobectomy or segmentectomy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 118 (estimated) |
| Sponsor | Tongji Hospital Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Status | Recruiting |
| Started | March 18, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | January 31, 2027 |
| Registry record updated | April 8, 2026 |
| Trial ID | NCT07386626 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–75 undergoing elective thoracoscopic lobectomy or segmentectomy with ASA I–III and BMI 18–30 who can give informed consent are the intended participants.
✕Probably not a fit
Patients who are pregnant or breastfeeding, have severe respiratory or cardiovascular disease, severe liver or kidney dysfunction, sleep apnea, opioid dependence, allergies to study drugs, or other major contraindications are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center interventional study at Tongji Hospital combines an early intercostal nerve block (ICNB) with patient-controlled intravenous tegileridine to cover both immediate incision pain and later central/visceral pain after thoracoscopic lung resection. Patients receive perioperative ICNB and postoperative patient-controlled analgesia with tegileridine, with interventions listed to include sufentanil as a comparator or reference analgesic. The approach aims to provide rapid incision analgesia from the block and sustained central analgesia from tegileridine while reducing common opioid side effects. Primary outcomes will focus on postoperative pain scores, opioid consumption, recovery metrics, and incidence of chronic post-surgical pain.
Why it matters
Potential benefit: If successful, the combination could give faster and more stable pain relief after thoracoscopic lung surgery, speed recovery, reduce opioid side effects, and lower the risk of chronic post-surgical pain.
How similar studies have gone: Multimodal approaches that combine regional nerve blocks with systemic analgesics have previously reduced acute pain and opioid use after thoracic surgery, although tegileridine itself is less widely studied than standard opioids.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age range: 18 to 75 years old; * Patients undergoing elective thoracoscopic lobectomy or segmentectomy; * ASA classification levels I-III; * BMI 18 \~ 30 kg/m2。 * Voluntarily participate and sign an informed consent form. Exclusion Criteria: * Patients with preoperative alcohol dependence and long-term use of analgesic drugs are receiving analgesic treatment for other acute and chronic pain; * Pregnant or lactating women; * Allergies or other contraindications to the anesthetics, analgesics, and antiemetic drugs used in the study; * Patients with severe sleep apnea syndrome or acute or severe bronchial asthma; * Suffering from mental and neurological disorders or cognitive impairment, known or suspected gastrointestinal obstruction, severe liver and kidney dysfunction (Child Pugh score C), chronic obstructive pulmonary disease or severe cardiovascular disease, etc; * Researchers consider participants who are not suitable to participate in this study and those who refuse to participate.
Where it's running
-
Tongji hospital
Wuhan, Hubei, China Recruiting
Study contacts
- Study coordinator: Aijun Xu, Dr.
- Email: ajxu@tjh.tjmu.edu.cn
- Phone: 18627784217
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Force feedback in robotic lung resection: does gentler instrument touch help recovery?
This study tests whether using Force Feedback instruments during robotic lobectomy or segmentectomy leads to faster recovery and fewer complications for adults undergoing these procedures.
-
Visual feedback in inspiratory muscle training after lobectomy
This study tests whether adding a mobile app with visual feedback to inspiratory muscle training helps lung cancer patients after lobectomy by improving motivation, adherence, and comfort while breathing.
-
Pre-incisional ropivacaine plus diprospan to relieve pain after VATS
This study tests whether injecting ropivacaine with diprospan before surgery can reduce postoperative pain for adults and children undergoing VATS lung surgery.
-
Transoral (TOETVA) versus standard front‑neck (anterior cervical) thyroid surgery for lobectomy or thyroidectomy
This trial will test whether the transoral (TOETVA) scar‑hiding approach works as well and is as safe as the standard front‑neck (anterior cervical) operation for adults needing lobectomy or thyroidectomy.
-
Using auricular acupressure to improve health before lung surgery
This study is testing whether auricular acupressure can help improve the health and well-being of people aged 50 and older who are getting ready for major lung surgery.
-
Left-sided stellate ganglion block to lower post-surgery atrial fibrillation risk
This will test if giving an ultrasound-guided left stellate ganglion block with bupivacaine to adults having esophagectomy, pneumonectomy, or lobectomy lowers their chance of atrial fibrillation after surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.